Pharmaceutical microbiology: key developments 2022
European Pharmaceutical Review
JANUARY 16, 2023
This also occupies a large resource, given the US Food and Drug Administration (FDA) requirement for double plate checking using a second ‘independent’ person. Tony Cundell: Perhaps the second greatest challenge is the ongoing transition from products based on small molecules to large molecules to cellular therapies.
126 
Let's personalize your content